Sample results
Hemolytic Disease of the Fetus and Newborn (HDFN) is a serious blood disorder where a pregnant woman's immune system attacks her baby's red blood cells. It is caused by blood group incompatibility, most commonly when an Rh-negative mother carries an Rh-positive baby and produces antibodies against the Rh D antigen. The Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing is the most important test for diagnosing HDFN and assessing risk during pregnancy.
HDFN is caused by blood group incompatibility between mother and baby, most commonly Rh incompatibility. When an Rh-negative mother carries an Rh-positive fetus, her immune system may become sensitized to the Rh D antigen, typically during a previous pregnancy, miscarriage, or blood transfusion. Once sensitized, the mother's body produces antibodies that cross the placenta and attack the baby's red blood cells, leading to hemolysis (destruction of red blood cells), anemia, jaundice, and potentially life-threatening complications for the newborn.
The Antibody Screen, RBC with Reflex to Identification, Titer, and Antigen Typing is the most important test for HDFN because it detects maternal antibodies against red blood cell antigens that cause the disease. This comprehensive test not only screens for the presence of antibodies but automatically identifies the specific antibody type (such as anti-D, anti-Kell, or anti-c), measures antibody concentration through titer levels, and performs antigen typing to confirm blood group incompatibilities. This complete profile allows healthcare providers to assess the severity of risk, determine how closely the pregnancy needs to be monitored, and plan interventions such as Rh immune globulin (RhoGAM) administration or intrauterine transfusions if needed.
You should get tested if you are pregnant and have Rh-negative blood, especially if this is not your first pregnancy or if you have a history of miscarriage, abortion, or blood transfusions. Testing is also essential if you experienced any bleeding during pregnancy, had an amniocentesis or other invasive prenatal procedure, or if the baby's father is Rh-positive or has unknown blood type. Early antibody screening, typically performed during the first prenatal visit and again around 28 weeks of pregnancy, allows your healthcare provider to identify risk factors and implement preventive measures before HDFN develops.
What this means
Your testosterone levels are slightly below the optimal range. While this is not necessarily cause for concern, it may contribute to occasional fatigue, reduced motivation, or lower muscle mass over time.
Recommended actions
Increase resistance or strength training
Prioritize 7–8 hours of quality sleep per night, try to reduce stress
Include more zinc- and magnesium-rich foods (like shellfish, beef, pumpkin seeds, spinach)
Consider retesting in 3–6 months
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: